Skip to main content
FinSpry Logo
FinSpry
ESPR logo
ESPR
(NASDAQ)
Esperion Therapeutics, Inc.
$2.61-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Esperion Therapeutics (ESPR) Stock Price & Financial Analysis

Esperion Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.52 - $2.66
52-Week High$4.18
52-Week Low$0.69
Open$2.55
Volume5.84M
Average Volume (3M)5.84M
Market Cap542.53M
Shares Outstanding207.87M
Price to Sales (P/S)1.35
EV/EBITDA14.70
Revenue (TTM)403.13M
Net Income (TTM)-22.68M
Free Cash Flow (TTM)-13.28M
EPS (TTM)$-0.08
Profit Margin-5.63%
Operating Margin14.95%
50-Day MA$3.07
200-Day MA$2.68
52-Week Change85.11%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Esperion Therapeutics

What is the current stock price for ESPR?

As of the latest trading session, ESPR stock trades at $2.61. The 52-week range is $0.69–$4.18, with a day range of $2.52–$2.65.

What is the P/E ratio for ESPR?

The P/E ratio (Price-to-Earnings) for ESPR is shown in the Key Statistics section. This valuation metric helps compare Esperion Therapeutics, Inc. to industry peers.

Does ESPR pay dividends?

Esperion Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ESPR?

Based on 3 analysts, the consensus for ESPR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ESPR?

Esperion Therapeutics's market capitalization is $542.5M, classifying it as a small-cap company. Esperion Therapeutics operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.